Quest Diagnostics Incorporated (DGX) Dividends

Quest Diagnostics Incorporated (DGX): $142.30

-2.71 (-1.87%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Dividend Yield and Dividend History Highlights

  • If you're seeking price stability while collecting dividends, note that DGX has less volatility in its price than 96.82% of US stocks in our dividend set.
  • Currently, DGX generates more cash flow over the 12 months prior than 85.97% of US dividend stocks.
  • As for stocks whose price is uncorrelated with DGX's price and thus may be suitable peers for a diversified dividend portfolio, check out the following: BWL.A, BGSF, UIHC, ALRM and EQC.
DGX Ex-Dividend Date
DGX Dividend Yield
1.74%
DGX Annual Dividend
$2.48
DGX Payout Ratio

DGX Price Forecast Based on Dividend Discount Model

Current PriceDDM Fair Value Target: Forecasted Gain:
$142.30$2194.62 1391.52%

The Dividend Discount Model (DDM) is a valuation model that attempts to determine a fair share price for a stock, based on the dividend it provides in comparison to several company-specific metrics indicative of the riskiness of the stock and the financial health of the company. Regarding Quest Diagnostics Inc, the DDM model generated by StockNews estimates a return of positive 1391.52% in comparison to its current price. Some interesting points we thought investors may wish to consider regarding the dividend discount model forecast for Quest Diagnostics Inc are:

  • Compared to other dividend issuers in the large-sized market cap category, DGX has a beta lower than 96.75% of them.
  • Regarding its relative worth based on the dividend discount model, Quest Diagnostics Inc's estimated return of 1391.52% surpasses about 95.7% of dividend issuers we applied the dividend discount model to.

DGX Dividend Chart


DGX Dividend History

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...


DGX Dividends vs. Peers

DGX's dividend yield currently ranks #3 of 85 vs. its peers in the Medical - Diagnostics/Research category.
Rank Symbol Name Dividend Yield
1 NRCIB National Research Corporation 5.00%
2 PMD Psychemedics Corporation 2.79%
3 DGX Quest Diagnostics Incorporated 1.74%
4 ABAX ABAXIS, Inc. 0.87%
5 A Agilent Technologies, Inc. 0.58%
6 BRKR Bruker Corporation 0.23%
7 TMO Thermo Fisher Scientific Inc. 0.17%
8 BIOC Biocept, Inc. 0.00%
9 DRIO DarioHealth Corp. 0.00%
10 NEO NeoGenomics, Inc. 0.00%
11 NEOG Neogen Corporation 0.00%
12 CNTG CENTOGENE N.V. 0.00%
13 ONVO Organovo Holdings, Inc. 0.00%
14 ICLR ICON plc - Ordinary Shares 0.00%
15 LNTH Lantheus Holdings, Inc. 0.00%
16 PRAH PRA Health Sciences, Inc. 0.00%
17 WAT Waters Corporation 0.00%
18 NSTG NanoString Technologies, Inc. 0.00%
19 OCX OncoCyte Corporation 0.00%
20 NTRA Natera, Inc. 0.00%
21 IDXG Interpace Biosciences, Inc. 0.00%
22 PRXL PAREXEL International Corporation 0.00%
23 NVDQ Novadaq Technologies Inc 0.00%
24 SYNH Syneos Health, Inc. - 0.00%
25 GENE Genetic Technologies Ltd. ADR 0.00%
26 BIO Bio-Rad Laboratories, Inc. 0.00%
27 LOGC LogicBio Therapeutics, Inc. 0.00%
28 MYNZ Mainz Biomed B.V. 0.00%
29 GHDX Genomic Health, Inc. 0.00%
30 VNRX VolitionRX Limited 0.00%
31 ALR Alere Inc. 0.00%
32 TROV TrovaGene, Inc. 0.00%
33 MDXH MDxHealth SA 0.00%
34 QTRX Quanterix Corporation 0.00%
35 CO Global Cord Blood Corporation 0.00%
36 NVTA Invitae Corporation 0.00%
37 CODX Co-Diagnostics, Inc. 0.00%
38 QDEL Quidel Corporation 0.00%
39 QGEN Qiagen N.V. 0.00%
40 ANIX Anixa Biosciences, Inc. 0.00%
41 SQL SeqLL, Inc. 0.00%
42 SMLR Semler Scientific Inc. 0.00%
43 IQV IQVIA Holdings, Inc. 0.00%
44 EXAS Exact Sciences Corporation 0.00%
45 OPGN OpGen, Inc. 0.00%
46 MTD Mettler-Toledo International, Inc. 0.00%
47 CRL Charles River Laboratories International, Inc. 0.00%
48 OLK Olink Holding AB (publ) 0.00%
49 RDNT RadNet, Inc. 0.00%
50 CDNA CareDx, Inc. 0.00%
51 BVS Bioventus Inc. 0.00%
52 OPK Opko Health, Inc. 0.00%
53 OXFD Oxford Immunotec Global PLC - Ordinary Shares 0.00%
54 ENZ Enzo Biochem, Inc. ($0.01 Par Value) 0.00%
55 HBIO Harvard Bioscience, Inc. 0.00%
56 KANG iKang Healthcare Group, Inc. 0.00%
57 CEMI Chembio Diagnostics, Inc. 0.00%
58 LH Laboratory Corporation of America Holdings 0.00%
59 PACB Pacific Biosciences of California, Inc. 0.00%
60 SRDX Surmodics, Inc. 0.00%
61 CELC Celcuity Inc. 0.00%
62 LMDX LumiraDx Limited 0.00%
63 AXDX Accelerate Diagnostics, Inc. 0.00%
64 MXCT MaxCyte, Inc. 0.00%
65 SHC Sotera Health 0.00%
66 CGIX Cancer Genetics, Inc. 0.00%
67 FLDM Fluidigm Corporation 0.00%
68 BASI Bioanalytical Systems, Inc. 0.00%
69 XGN EXAGEN INC. 0.00%
70 FLGT Fulgent Genetics, Inc. 0.00%
71 ME 23andMe Holding Co. Class A Common Stock 0.00%
72 FMI Foundation Medicine, Inc. 0.00%
73 ISPC iSpecimen Inc. 0.00%
74 VIVO Meridian Bioscience Inc. 0.00%
75 MYGN Myriad Genetics, Inc. 0.00%
76 SENS Senseonics Holdings, Inc. 0.00%
77 BEAT BioTelemetry, Inc. 0.00%
78 AKU Akumin Inc. 0.00%
79 HSKA Heska Corporation 0.00%
80 DMTK DermTech, Inc. 0.00%
81 BMRA Biomerica, Inc. 0.00%
82 BRBR BELLRING BRANDS, INC. 0.00%
83 IRTC iRhythm Technologies, Inc. 0.00%
84 HTGM HTG Molecular Diagnostics, Inc. 0.00%
85 VRML Vermillion, Inc. 0.00%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.763 seconds.